Nobel Biocare announced today that Oskar K. Ronner has withdrawn his shareholder proposal and informed the Board that he and his two proposed candidates will not run for election to the Board of Directors of the Company. The Board acknowledges this decision although it would have welcomed Mr. Ronner joining the Board.
All current members of the Board of Directors will stand for re-election at the Annual General Meeting on 28 March 2013. As already announced on 18 January 2013, Franz Maier will be proposed as a new member of the Board. The invitation to the Annual General Meeting and the complete agenda will be published in late February.
After the General Meeting, the Board of Directors will constitute itself and will elect Dr. Rolf Watter as Chairman of the Board of Directors. It will also decide on the committees and their composition.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.